Abstract
The purpose of this report is to analyze and describe the nuclear cardiology
market segments in the U.S. and worldwide. It examines the measurement devices
that are utilized by physicians to diagnose and monitor heart diseases. This
study also discusses key products in nuclear cardiology and examines the
trends that are stimulating this market. It includes a survey of all major
companies actively engaged in marketing, manufacturing or developing nuclear
cardiological instrumentation, with each company discussed in depth. The main
objectives of this analysis are to:
- Identify viable technology drivers through a comprehensive look at
platform technologies for nuclear cardiology testing.
- Obtain a complete understanding of the individual nuclear cardiology
testing platforms from their basic principles to their clinical applications.
- Discover feasible market opportunities by identifying high-growth
applications in different clinical diagnostic areas.
- Focus on global industry developments through an in-depth analysis of the
major world markets for nuclear cardiology technology, including growth
forecasts.
- Present market figures related to the current value of nuclear cardiology,
market projections, market share, key players, and sector growth rates.
An analysis of the nuclear cardiology market must include several key areas of
related activity. The most important segments discussed in this report include:
- Hardware (e.g., nuclear cardiology instrumentation).
- Software (e.g., nuclear cardiology image processing, PACS).
- Radiopharmaceuticals and pharmaceuticals.
- Ancillary products.
- Service and support.
View Cart
